Ujwala Mahatme is a director of Summit Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
2 Jan 24 | SMMT Summit Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.32 | 52,575 | 69.40 k | 87,575 |
2 Jan 24 | SMMT Summit Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 2.64 | 35,000 | 92.40 k | 35,000 |
3 Jan 23 | SMMT Summit Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.67 | 40,500 | 67.64 k | 75,500 |
3 Jan 23 | SMMT Summit Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 5 | 35,000 | 175.00 k | 35,000 |